UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of November 2021
Commission File Number: 001-40277
OLINK HOLDING AB (PUBL)
(Translation of registrant’s name into English)
Uppsala Science Park
SE-751 83
Uppsala, Sweden
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Enclosed hereto is a copy of an announcement published by Olink Holding AB (publ) on November 5, 2021.
The information contained in this Form 6-K, including Exhibit 99.1, is intended to be furnished and shall not be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as set forth by specific reference to such filing.
EXHIBITS
| Exhibit Number | Description | |
| 99.1 | Olink Holding AB (publ) announcement dated November 5, 2021. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| OLINK HOLDING AB (PUBL) | ||
| Date: November 5, 2021 | by: | /s/ Jon Heimer |
| Jon Heimer | ||
| Chief Executive Officer | ||
Exhibit 99.1
Olink announces participation in November investor events
UPPSALA, Sweden, November 5, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that it will be participating in two investor events in November.
Olink virtual investor day with proteomics KOLs
On November 15th, 2021, from 12:30pm to 3:30pm ET (6:30pm to 9:30pm CET), Olink will host a virtual investor day, providing direct access to key opinion leaders from leading universities and BioPharma companies, discussing exciting research projects where Olink is a proud contributor, while also providing an overview of Olink’s commercial plans.
Nordic Post IPO Seminar 2021
Oskar Hjelm, CFO, will participate in the Nordic Post IPO Seminar 2021, on November 24th, from 4:00am to 4:45am ET (10:00am to 10:45 am CET) hosted by Handelsbanken Capital Markets.
About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.
Olink IR Contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com
Olink Media Contact
Andrea Prander
Corporate Communications Manager
Mobile: + 46 768 775 275
andrea.prander@olink.com